Maynard Um
-
-
-
-
-
-
-
Zai Lab wins China approval for cervical cancer drug TIVDAK
-
-
-
-
-
-
-
China approves Zai Lab's AUGTYRO for NTRK-positive solid tumors
-
-
-
-
-
-
-
ZAI LAB receives china medical device designation for pancreatic cancer therapy
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Tops Q1 EPS by 42c
-
-
-
-
-
-
-
Scotiabank Starts Zai Lab (ZLAB) at Sector Outperform
-
-
-
-
-
-
-
Zai Lab (ZLAB) and Vertex (VRTX) Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
-
-
-
-
-
-
-
Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: 'We believe it should bode moderately positively for ZLAB shares'
-
466,312 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


